U.S. FDA Clears MedCognetics’ AI-Enabled Breast Cancer Screening Software
Digital health company MedCognetics, Inc. announces that it has received U.S. FDA 510(k) clearance of its artificial intelligence-enabled software for breast cancer screening, QmTRIAGE.